Citation Tools

Download PDFPDF

387 A Phase II, multicenter study of the safety and efficacy of LAG525 in combination with spartalizumab in patients with advanced malignancies

Download to a citation manager

Cite this article as:
Lin C, Garralda E, Schöffski P, et al
387 A Phase II, multicenter study of the safety and efficacy of LAG525 in combination with spartalizumab in patients with advanced malignancies